The Journey of the Unknown Primary in the HPV Era: Evaluation, Treatment, Surveillance and Management of Oligometastatic Disease
Management of unknown primary head and neck squamous cell carcinomas has evolved as the incidence of p16 positive disease among head and neck cancer patients has increased.
Category
- Head and Neck
- Oligometastatic
Format
- Sessions onDemand
Credits
- 1.25 AMA PRA Category 1 Credit™
- 1.25 Certificate of Attendance
Cost $149.00
Role of Radiation in Oligometastatic and Polymetastatic Disease
Radiation therapy continues to make significant strides in the management of early-stage and locally advanced solid tumor malignancies.
Category
- SBRT
- Oligometastatic
Format
- Sessions onDemand
Credits
- 2.00 AMA PRA Category 1 Credit™
- 2.00 Certificate of Attendance
Cost $149.00

Facebook
X
LinkedIn
Forward